普鲁宁:一种新兴的抗癌类黄胺
Juie Nahushkumar Rana1, Sohail Mumtaz2
1Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
International journal of molecular sciences
|March 27, 2025
概括
普鲁宁是一种植物衍生的黄类化合物,通过调节细胞通路,显示出有前途的抗癌作用. 本综述探讨了其作为一种安全,有效的癌症治疗和辅助治疗的潜力,并通过纳米配方增强了其功能.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 开发安全有效的癌症疗法仍然至关重要.
- 黄类化合物,如普鲁宁,是植物衍生化合物,具有潜在的治疗益处.
- 普鲁宁的抗癌机制和生物医学应用需要进一步的科学研究.
研究的目的:
- 审查普鲁宁作为抗癌剂的治疗潜力.
- 阐明普鲁宁抗癌作用背后的分子机制.
- 探索普鲁宁在辅助癌症治疗和创新的输送系统中的作用.
主要方法:
- 对普鲁宁药理性质的文献综述.
- 对普鲁宁对关键细胞通路的影响进行分析.
- 讨论普鲁宁在组合疗法和纳米配方中的潜力.
主要成果:
- 普鲁宁具有抗氧化,抗炎和抗癌的特性.
- 普鲁宁调节了参与癌症进展的关键细胞通路.
- 普鲁宁可以增强传统治疗反应,克服药物耐药性.
结论:
- 普鲁宁显示出作为一种选择性和安全的抗癌剂的显著治疗潜力.
- 需要进一步研究prunin的分子机制和传递系统.
- 基于普鲁宁的疗法,包括纳米配方,可以推进癌症治疗策略.
更多相关视频
相关概念视频
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Positive Regulator Molecules
105.6K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K


